Formononetin, a plant compound that helps decrease immunoglobulin E (IgE) production, is found highly potential as a therapeutic candidate to treat food allergies in a new study by a team of medical scientists led by Dr Ibrahim Musa, a doctoral candidate in pathology, microbiology and immunology at New York Medical College. The findings of the study, which will be presented at the American Society for Biochemistry and Molecular Biology annual meeting this month, indicate new mechanisms and targets pertaining to formononetin that can be utilised to design future drugs against food allergies and the like.